Synthetic Cannabinoid 4F-MDMB-BUTICA Causes Developmental Toxicity and Gene Changes in Zebrafish

The synthetic cannabinoid 4F-MDMB-BUTICA caused dose-dependent mortality, deformities, hypoactivity, and altered expression of 19 genes in zebrafish embryos.

Kullebi, Berşan et al.·Journal of applied toxicology : JAT·2025·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-06870Animal StudyPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

LC50: 1.932 mg/L; EC50: 0.960 mg/L at 120 hours. Deformities: spine malformation, pericardial edema, yolk sac edema, delayed development. Hypoactivity in larvae. Gene changes in apoptosis, dopamine, serotonin, GABA, and behavior pathways.

Key Numbers

LC50: 1.932 mg/L; EC50: 0.960 mg/L; 19 genes assessed; 6 concentrations; no acute effects, all effects subacute.

How They Did This

Zebrafish embryos exposed at 0.15-4.80 mg/L. Acute (3-24 hpf) and subacute (3-120 hpf) exposure. Morphology, behavior, and qPCR on 19 genes assessed.

Why This Research Matters

First embryotoxicity data on this new synthetic cannabinoid, revealing multi-system effects that suggest significant developmental risk.

The Bigger Picture

Synthetic cannabinoids emerge faster than safety data. Zebrafish screening provides rapid toxicity flags.

What This Study Doesn't Tell Us

Zebrafish model limits mammalian translation. Single compound. No THC comparison.

Questions This Raises

  • ?How does this compare to other synthetic cannabinoids?
  • ?Are zebrafish gene changes relevant to humans?

Trust & Context

Key Stat:
LC50 of 1.932 mg/L at 120 hours
Evidence Grade:
Systematic dose-response with multi-level outcomes, but zebrafish model limits human translation.
Study Age:
2025 study with first embryotoxicity data on 4F-MDMB-BUTICA.
Original Title:
Embryotoxicity Evaluation of Novel Synthetic Cannabinoid 4F-MDMB-BUTICA Using Zebrafish Embryos.
Published In:
Journal of applied toxicology : JAT, 45(7), 1314-1330 (2025)
Database ID:
RTHC-06870

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is 4F-MDMB-BUTICA?

A new-generation synthetic cannabinoid designed to mimic THC but with higher potency and unpredictable toxicity.

Are synthetic cannabinoids dangerous in pregnancy?

This zebrafish study found developmental deformities and gene changes, suggesting significant risk though human translation is uncertain.

Read More on RethinkTHC

Cite This Study

RTHC-06870·https://rethinkthc.com/research/RTHC-06870

APA

Kullebi, Berşan; Alat, Ömercan; Aksakal, Özkan; Yılmaztürk, Derya; Lafzi, Ayşe; Şişman, Turgay. (2025). Embryotoxicity Evaluation of Novel Synthetic Cannabinoid 4F-MDMB-BUTICA Using Zebrafish Embryos.. Journal of applied toxicology : JAT, 45(7), 1314-1330. https://doi.org/10.1002/jat.4778

MLA

Kullebi, Berşan, et al. "Embryotoxicity Evaluation of Novel Synthetic Cannabinoid 4F-MDMB-BUTICA Using Zebrafish Embryos.." Journal of applied toxicology : JAT, 2025. https://doi.org/10.1002/jat.4778

RethinkTHC

RethinkTHC Research Database. "Embryotoxicity Evaluation of Novel Synthetic Cannabinoid 4F-..." RTHC-06870. Retrieved from https://rethinkthc.com/research/kullebi-2025-embryotoxicity-evaluation-of-novel

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.